Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > cretostimogene will likely end up in the 70+% range CR
View:
Post by Dumbeldorfwhite on Dec 13, 2023 3:08pm

cretostimogene will likely end up in the 70+% range CR

17/25 right now CR with another 6 CR heading towards 12 month, yikes not good for us.
Comment by Dumbeldorfwhite on Dec 13, 2023 3:13pm
This board hates math!
Comment by CAinPlap on Dec 13, 2023 3:18pm
So you think TLT is done for as Core is so much better in your opinion. I would assume you will be selling any investment you may have in TLT to purchase your new favorite stock Core. According to your analysis, TLT is likely to go down and COre go up. Cmon you can use your losses on TLT to shield all your gains on Core.  I would also expect to go to the COre chat board and see you singing ...more  
Comment by Dumbeldorfwhite on Dec 13, 2023 3:26pm
Lazy post, didn't even take the time to see OCG is privately owned
Comment by socksnblonds642 on Dec 13, 2023 3:59pm
AHA so you admit that their stock value is $.0.00 while TLT has skyrocketed almost 14% since the end of Novemeber. 
Comment by CAinPlap on Dec 13, 2023 4:13pm
Yes I see that now. Doesn't change my assessment of your motives.
Comment by Dumbeldorfwhite on Dec 13, 2023 5:19pm
I would gladly sell back at my original price 
Comment by Alamir1111 on Dec 13, 2023 5:53pm
Cmon DW don't  be a quitter 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250